XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 6,951 $ 7,616
Short-term investments 331 351
Trade receivables, less allowances of $471 in 2025 and $439 in 2024 7,972 6,925
Inventories:    
Finished products 4,319 3,700
Work in process 962 840
Materials 1,673 1,654
Total inventories 6,954 6,194
Prepaid expenses and other receivables 2,260 2,570
Total Current Assets 24,468 23,656
Investments 958 886
Property and equipment, at cost 24,472 22,740
Less: accumulated depreciation and amortization 13,077 12,082
Net property and equipment 11,395 10,658
Intangible assets, net of amortization 5,920 6,647
Goodwill 23,952 23,108
Deferred income taxes and other assets 17,306 16,459
Total Assets 83,999 81,414
Current Liabilities:    
Trade accounts payable 4,306 4,195
Salaries, wages and commissions 1,550 1,701
Other accrued liabilities 5,656 5,143
Dividends payable 1,030 1,024
Income taxes payable 390 594
Current portion of long-term debt 507 1,500
Total Current Liabilities 13,439 14,157
Long-term debt 12,930 12,625
Post-employment obligations, deferred income taxes and other long-term liabilities 6,801 6,731
Commitments and Contingencies
Shareholders’ Investment:    
Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued 0 0
Common shares, without par value Authorized — 2,400,000,000 shares Issued at stated capital amount — Shares: 2025: 1,996,448,469; 2024: 1,991,472,630 25,284 25,153
Common shares held in treasury, at cost — Shares: 2025: 255,988,730; 2024: 259,774,639 (16,610) (16,844)
Earnings employed in the business 48,467 47,261
Accumulated other comprehensive income (loss) (6,576) (7,906)
Total Abbott Shareholders’ Investment 50,565 47,664
Noncontrolling Interests in Subsidiaries 264 237
Total Shareholders’ Investment 50,829 47,901
Total Liabilities and Shareholders' Investment $ 83,999 $ 81,414